ORKA Q1 2019 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$21,000

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-22.29

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$9M

Total Liabilities

$1M

Stockholders' Equity

$7M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$21,000	-$6,000	-250.0%
Operating Income	-$2M	-$3M	+35.8%
Net Income	-$2M	-$3M	+39.2%